Article
Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers
3 Oct 2012
Abstract excerpt
BACKGROUND: Accurate outcome prediction in neuroblastoma, which is necessary to enable the optimal choice of risk-related therapy, remains a challenge. To improve neuroblastoma patient stratification, this study aimed to identify prognostic tumor DNA methylation biomarkers. RESULTS: To identify genes silenced by promoter methylation, we first applied two independent genome-wide methylation screening methodologies...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
